Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry
DOI 10.1016/j.eurpsy.2009.01.005

Cited by (948)

Items 901–948 of 948

  1. The dynamic psychoendocrine relation between diabetes mellitus and mental health disorders: A review of the literature
    Mohamad Fleifel, Dana El Masri, Hicham Baba, Amal Al Zoghbi, Andrew El Alam, Yara Skaff, Khaled Abi Farraj, Lynn Daoud, Omar El Tarras · 2025 · Endocrine and Metabolic Science
  2. Exploring the challenges of managing diabetes mellitus in an in-patient psychiatric setting
    Elegia Clancey, Parveen Dhesi, Prachi Patel, Ioanna Zimianiti, M. Biswas · 2025 · BJPsych Advances
  3. Forensic analysis of psychiatric disorder-related deaths: A retrospective study in southern China
    Jinqi Wang, Kexin Ye, Chengdong Ma, Ying Fang, Yangchang Ou, Erwen Huang, Shuquan Zhao · 2025 · Journal of Forensic and Legal Medicine
  4. Implementation of a Cardiopsychiatry Clinic for Cardiovascular Primary Prevention in Individuals with Severe Mental Illness
    Marina Delli Colli, Soham Rej, Daniel Frank, Kyle T. Greenway, Michael Goldfarb · 2025 · Journal for Healthcare Quality
  5. Additional file 3 of The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions
    Carswell, C., Brown, J. V. E., J. Lister, Ajjan, R. A., Alderson, S. L., Balogun-Katung, A., Bellass, S., Keith Double, Gilbody, S., Hewitt, C. E. et al. · 2022 · Figshare
  6. Additional file 2 of Are diabetes self-management programmes for the general diabetes population effective for people with severe mental illness?: a systematic review
    Anne Coxon, McBain, Hayley, Neli T. Pavlova, Hannah Rowlands, Kathleen Mulligan · 2020 · Figshare
  7. Additional file 1 of Are diabetes self-management programmes for the general diabetes population effective for people with severe mental illness?: a systematic review
    Anne Coxon, McBain, Hayley, Neli T. Pavlova, Hannah Rowlands, Kathleen Mulligan · 2020 · Figshare
  8. Additional file 2 of The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol
    Lindekilde, N., Scheuer, S., Femke Rutters, Henriksen, J. E., Rubin, K. H., Lasgaard, M., Andersen, G. S., Pouwer, F. · 2020 · Figshare
  9. Additional file 1 of The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol
    Lindekilde, N., Scheuer, S., Femke Rutters, Henriksen, J. E., Rubin, K. H., Lasgaard, M., Andersen, G. S., Pouwer, F. · 2020 · Figshare
  10. Additional file 1 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review
    Dolly Sud, Eileen Laughton, Robyn McAskill, Bradley, Eleanor, Maidment, Ian · 2021 · Figshare
  11. Additional file 1 of Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients
    Davy M C Quadackers, Edith Jantine Liemburg, Fionneke Marijke Bos, Bennard Doornbos, Arne Risselada, Marjolein Y. Berger, Ellen Visser, Daniëlle C. Cath · 2023 · Figshare
  12. Additional file 2 of Mental health care use and quality among Medicaid adults with serious mental illness receiving care at Federally Qualified Health Centers vs. other settings
    Catherine Myong, Zhiyou Yang, Caroline Behr, Vicki Fung · 2024 · Figshare
  13. Additional file 2 of The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions
    Carswell, C., Brown, J. V. E., Lister, J., Ajjan, R. A., Alderson, S. L., Balogun-Katung, A., Bellass, S., Keith Double, Gilbody, S., Hewitt, C. E. et al. · 2022 · Figshare
  14. Additional file 2 of Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients
    Davy M C Quadackers, Edith Jantine Liemburg, Fionneke Marijke Bos, Bennard Doornbos, Arne Risselada, Marjolein Y. Berger, Ellen Visser, Daniëlle C. Cath · 2023 · Figshare
  15. Additional file 2 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review
    Dolly Sud, Eileen Laughton, Robyn McAskill, Eleanor Bradley, Maidment, Ian · 2021 · Figshare
  16. Additional file 1 of The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions
    Carswell, C., Brown, J. V. E., J. Lister, Ajjan, R. A., Alderson, S. L., Balogun-Katung, A., Bellass, S., Keith Double, Gilbody, S., Hewitt, C. E. et al. · 2022 · Figshare
  17. Additional file 1 of Study protocol for a pilot high-intensity interval training intervention in inpatient mental health settings: a two-part study using a randomised controlled trial and naturalistic study design
    Rebecca Martland, Juliana Onwumere, Stubbs, Brendon, Fiona Gaughran · 2021 · Figshare
  18. Additional file 1 of Mental health care use and quality among Medicaid adults with serious mental illness receiving care at Federally Qualified Health Centers vs. other settings
    Catherine Myong, Zhiyou Yang, Caroline Behr, Vicki Fung · 2024 · Figshare
  19. Additional file 1 of High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
    H.-Y. Li, Chen, Chi, Chen, Yi, Han, Bing, Chen, Yingchao, Jing Cheng, Wang, Ningjian, Wang, Bin, Yingli Lu · 2023 · Figshare
  20. Additional file 3 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review
    Dolly Sud, Eileen Laughton, Robyn McAskill, Eleanor Bradley, Maidment, Ian · 2021 · Figshare
  21. Negative Symptoms in Schizophrenia: The Role of Pharmacotherapy
    István Bitter, Pál Czobor · 2025 · Comprehensive approach to psychiatry
  22. Schizophrenia
    Adriana E. Foster, Jordanne King · 2026 · Springer eBooks
  23. Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence
    Ramya Padmavathy Radha Krishnan, Helga Zoëga, Nicholas Allan Buckley, Jacques Raubenheimer · 2026 · Epidemiology and Psychiatric Sciences
  24. Metabolic syndrome among patients with severe mental illness attending a tertiary hospital in northwestern, Tanzania: A cross sectional study
    Didas Raymond Msele, Elig Kimosso, Florian Emanuel Ghaimo, Samuel Chacha, Mrema Noel Kilonzo, Matiko Mwita, Samuel Lazarus Likindikoki · 2026 · PLOS mental health.
  25. Genetic evidence for the association between schizophrenia and obesity
    Mei‐Hsin Su, Tzu-Chen Yeh, Chi‐Fung Cheng, Wei-Yi Kao, Mei‐Chen Lin, Yen-Feng Lin, Chia-Yen Chen, Chi‐Shin Wu, Shi‐Heng Wang · 2026 · International Journal of Obesity
  26. Caractérisation des perturbations métaboliques induites par les antipsychotiques dans un modèle murin : approches par la résonance magnétique
    Florent Auger · 2014
  27. Linking Brain, Hormones, and Metabolism: Pathophysiology and Treatment of Antipsychotic-Induced Cardiometabolic Side Effects
    Walter Milano, Roberta Campanile, Magda Marchese, Maria Francesca Milano, Ludovica Ragozino, Biancamaria Saetta, Anna Capasso · 2026 · OBM Neurobiology
  28. Managing metabolic syndrome in bipolar disorder: multidisciplinary monitoring and treatment strategies
    Jorge César Correia, Hélène Richard-Lepouriel, Anne Chalut-Carpentier, Zoltan Pataky · 2026 · Frontiers in Psychiatry
  29. Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study
    Yasuhiro Ohno, Kiyomi Saito, Keita Hanabusa, Ayaka Nakai, Tomoko Nagai, Noriko Hida, Kenji Sanada · 2026 · Neuropsychopharmacology Reports
  30. Psychotropic medication use, lifestyle, genetic risk for high BMI and the incidence of cardiovascular disease
    Nini de Boer, Iris Hanskamp, Bochao Danae Lin, Liese Boonstra, Marte Z. van der Horst, Kristel R. van Eijk, Marco P. Boks, Wouter J. Peyrot, Jos W. R. Twisk, Thomas Goldschmidt et al. · 2026 · Nature Mental Health
  31. Volumetric and Functional Features of Left Atrium in Chronic Schizophrenia—Detailed Analysis from Three-Dimensional Speckle-Tracking Echocardiographic MAGYAR-Path Study
    Attila Nemes, Renáta Halcsik, Árpád Kormányos, Nándor Gyenes, Asghar Keifari, Bence András Lázár, Csaba Lengyel, János Kálmán · 2026 · Biomedicines
  32. Empagliflozin as an Alternative to Metformin for Antipsychotic‐Related Weight Gain: Double‐Blind Randomized Controlled Trial
    Atena Dolati, Davoud Ahmadimoghaddam, Maryam Zamanirafe, Shabnam Rezaie, Salman Khazaie, Maryam Mehrpooya, Mona Doostizadeh · 2026 · Human Psychopharmacology Clinical and Experimental
  33. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2026)
    Heidemarie Abrahamian, Alexandra Kautzky‐Willer, Angelika Rießland-Seifert, Alexander Kautzky, Johanna Maria Brix, Birgit M Harb, Dora Beer, Diana Lebherz-Eichinger, Peter Fasching, Hermann Toplak · 2026 · Wiener klinische Wochenschrift
  34. Inequalities in Access to and Outcomes of Cardiac Surgery Among Patients with Mental Health Disorders
    Vasileios Leivaditis, Sofoklis Mitsos, Francesk Mulita, Andreas Antonios Maniatopoulos, Nikolaos G. Baikoussis, Ejona Shaska, Chrysa Andrikopoulou, Elias Liolis, Theodora Skoura, Andreas Antzoulas et al. · 2026 · Medical Sciences
  35. Small-Molecule Mimicry Intercepts PEX5 Recognition by Trypanosomal PEX14 as Revealed by Molecular Dynamics
    Amanda R. Guimarães, Esther R. S. Paz, Allison Serrano-Trejos, Chonny Herrera‐Acevedo, Iván Rivilla, Óscar R. Ballesteros, Caroline R. Kwawu, Guilherme A. M. Jardim, Eufrânio N. da Silva Júnior, Felipe Fantuzzi · 2026 · Research Square
  36. ADHD and cardiometabolic risk profile in adults with type 2 diabetes: a longitudinal register-based study
    Zihan Dong, Shengxin Liu, Cecilia Lundholm, Isabell Brikell, Ralf Kuja‐Halkola, Brian Matthew D'Onofrio, Paul Lichtenstein, Agnieszka Butwicka, Soffia Guðbjörnsdóttir, Henrik Larsson et al. · 2026 · BMJ Open
  37. From Catering to Clinical Care: An Expert Survey on Designing the Inpatient Psychiatric Meal Concept
    Timur Liwinski, Sandra Nussbaum, L. Imfeld, U. Wein, Undine E. Lang · 2026 · Nutrients
  38. A multidisciplinary expert consensus for enhancing recovery-oriented clinical practice in schizophrenia: The RECOVERY project
    Miquel Bernardo, María Fe Bravo‐Ortiz, Jara Domper, Vallina O, López-Cocera JA, García S, García-Heras S, García-Gimeno J, Martínez-García AM, Guillermo Lahera · 2026 · The European Journal of Psychiatry
  39. Supporting continuous glucose monitoring for people with serious mental illness and type 2 diabetes: a co-design study for a structured intervention
    Jennifer V. E. Brown, Olivia Matthias, Jessica Hendon, Ramzi Ajjan, Najma Siddiqi, Ian Kellar, Peter A Coventry · 2026 · Frontiers in Health Services
  40. Psychokardiologie
    Kai G. Kahl, Michael Deuschle, Frank Schneider · 2026 · Springer eBooks
  41. Retinal biomarker assessments in psychiatric disorders: perspective and roadmap from a data and methods sharing initiative
    Cemal Demirlek, Ali S. Raza, Finn Rabe, Florian J. Raabe, Kaitlyn A. Kaiser, Erik Vélez-Pérez, Daman Parduman Dhunna, Chelsea Kiely, Steve M. Silverstein, Halide Bilge Türközer et al. · 2026 · Nature Mental Health
  42. Fenofibrate Protects Against Antipsychotic‐Induced Hyperglycemia Through Weight Loss and FGF21 Dependent Mechanisms
    Michael Akcan, Stewart Jeromson, Bradley J. Baranowski, Annalaura Bellucci, Serena Trang, Katelyn Eisner, Ailish Babicki-Moore, Hadil Alfares, Meagan Arbeau, Kyle Medak et al. · 2026 · The FASEB Journal
  43. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Richard I. G. Holt, J. Hans DeVries, Amy Hess Fischl, Irl B. Hirsch, Marian Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Éric Renard et al. · 2026 · Diabetologia
  44. Acceptability of blinded continuous glucose monitoring for people with serious mental illness and type 2 diabetes: findings from an exploratory mixed-methods study
    Jennifer V. E. Brown, Ramzi Ajjan, Najma Siddiqi, Peter A Coventry · 2026 · Frontiers in Clinical Diabetes and Healthcare
  45. CardioPulse Articles
    Michelle Gillies, George David Batty, Pardeep S. Jhund · 2012 · European Heart Journal
  46. Besondere Situationen bei Diabetes mellitus
    M. Blüher, Wilfred Druml, M. Ehren, M. Hummel, Daniel Kopf, Karsten Müssig, Martin Pfohl, Ekkehard Schifferdecker · 2014 · Springer eBooks
  47. Psychiatrie in Europa: Stand der Dinge, Chancen und Herausforderungen
    Hans‐Jürgen Möller · 2011 · Springer eBooks
  48. Untitled work
    2015 · PubMed